Analysis: Big brain projects highlight drug research gaps | Reuters
Governments on both sides of the Atlantic are placing big new bets on the future of brain science, just as much of the pharmaceutical industry retreats from the field.
Brain disorders ranging from depression to Alzheimer's are extracting an ever greater social and economic cost across the globe. But while the United States and European Union are funding ambitious efforts in neuroscience, the private sector is often skeptical about the prospect of rapid breakthrough cures.
Many pharmaceutical companies harbor deep doubts about whether neuroscience is worth their investment dollars as a boom period for once highly profitable psychiatric medicines comes to an end and new drugs prove hard to find.
CiarĂ¡n Quinn, Research Support Librarian & Librarian for the Research Institutes, Maynooth University. ciaran.quinn@mu.ie
Subscribe to:
Post Comments (Atom)
World University Rankings 2023
The Times Higher Education World University Rankings 2023 include 1,799 universities across 104 countries and regions, making them the lar...
-
Extinctions of large animals sever the Earth's 'nutrient arteries' A new study has demonstrated that large animals have acted...
-
Entrez cross-database search Entrez is NCBI’s primary text search and retrieval system that integrates the PubMed database of biomedical ...
No comments:
Post a Comment